References

Arvanitidou, M., E. Katikaridou, J. Douboyas and A. Tsakris, 2005. Prognostic factors for nosocomial bacteraemia outcome: A prospective study in a Greek teaching hospital. J. Hosp. Infect., 61: 219-224.
CrossRef  |  Direct Link  |  

Asoodeh, A., S. Sepahi and A. Ghorani‐Azam, 2014. Purification and Modeling Amphipathic alpha helical antimicrobial peptides from skin secretions of Euphlyctis cyanophlyctis. Chem. Biol. Drug Des., 83: 411-417.
CrossRef  |  Direct Link  |  

Coban, Y.K., 2012. Infection control in severely burned patients. World J. Crit. Care Med., 1: 94-101.

Custovic, A., J. Smajlovic, N. Tihic, S. Hadzic, S. Ahmetagic and H. Hadzagic, 2014. Epidemiological monitoring of nosocomial infections caused by Acinetobacter baumannii. Med. Arch., 68: 402-406.

Dallo, S.F. and T. Weitao, 2010. Insights into acinetobacter war-wound infections, biofilms and control. Adv. Skin Wound Care, 23: 169-174.
CrossRef  |  Direct Link  |  

Dexter, C., G.L. Murray, I.T. Paulsen and A.Y. Peleg, 2015. Community-acquired Acinetobacter baumannii: Clinical characteristics, epidemiology and pathogenesis. Expert Rev. Anti-Infective Therapy, 13: 567-573.
Direct Link  |  

Eliopoulos, G.M., L.L. Maragakis and T.M. Perl, 2008. Acinetobacter baumannii: Epidemiology, antimicrobial resistance and treatment options. Clin. Infect. Dis., 46: 1254-1263.
Direct Link  |  

Eriksen, H.M., B.G. Iversen and P. Aavitsland, 2003. Prevalence of nosocomial infections in hospitals in Norway, 2002 and 2003. J. Hosp. Infect., 60: 40-45.
PubMed  |  

Fagon, J.Y., J. Chastre, Y. Domart, J.L. Trouillet and C. Gibert, 1996. Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species: Assessment by quantitative culture of samples obtained by a protected specimen brush. Clin. Infect. Dis., 23: 538-542.
CrossRef  |  Direct Link  |  

Farsiani, H., A. Mosavat, S. Soleimanpour, M.N. Nasab and H. Salimizand et al., 2015. Limited genetic diversity and extensive antimicrobial resistance in clinical isolates of Acinetobacter baumannii in North-East Iran. J. Med. Microbiol., 64: 767-773.
CrossRef  |  Direct Link  |  

Fournier, P.E., H. Richet and R.A. Weinstein, 2006. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin. Infect. Dis., 42: 692-699.
CrossRef  |  Direct Link  |  

Gilardi, G.L., 1969. Characterization of the oxidase-negative, gram-negative coccobacilli (the Achromobacter-Acinetobacter group). Antonie Leeuwenhoek, 35: 421-429.

Goldman, D.A. and W.C. Huskins, 1997. Control of nosocomial antimicrobial-resistant bacteria: A strategic priority for hospitals worldwide. Clin. Infec. Dis., 24: 139-145.
PubMed  |  Direct Link  |  

Gootz, T.D., 2010. The global problem of antibiotic resistance. Crit. Rev. Immunol., 30: 79-93.
CrossRef  |  

Kaul, R., J.A. Burt, L. Cork, H. Dedier and M. Garcia et al., 1996. Investigation of a multiyear multiple critical care unit outbreak due to relatively drug-sensitive Acinetobacter baumannii: Risk factors and attributable mortality. J. Infect. Dis., 174: 1279-1287.
CrossRef  |  Direct Link  |  

Kim, U.J., H.K. Kim, J.H. An, S.K. Cho, K.H. Park and H.C. Jang, 2014. Update on the epidemiology, treatment and outcomes of carbapenem-resistant Acinetobacter infections. Chonnam Med. J., 50: 37-44.
CrossRef  |  Direct Link  |  

Kooti, S., M. Motamedifar and J. Sarvari, 2015. Antibiotic resistance profile and distribution of oxacillinase genes among clinical isolates of Acinetobacter baumannii in Shiraz teaching hospitals, 2012-2013. Jundishapur J. Microbiol., Vol. 8, No. 8.

Lagamayo, E.N., 2008. Antimicrobial resistance in major pathogens of hospital-acquired pneumonia in Asian countries. Am. J. Infect. Control, 36: S101-S108.
CrossRef  |  Direct Link  |  

Liberati, A., D.G. Altman, J. Tetzlaff, C. Mulrow and P.C. Gotzsche et al., 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J. Clin. Epidemiol., 151: w65-w94.
CrossRef  |  Direct Link  |  

Lortholary, O., J.Y. Fagon, A.B. Hoi, M.A. Slama and J. Pierre et al., 1995. Nosocomial acquisition of multiresistant Acinetobacter baumannii: Risk factors and prognosis. Clin. Infect. Dis., 20: 790-796.
CrossRef  |  Direct Link  |  

Manchanda, V., S. Sanchaita and N.P. Singh, 2010. Multidrug resistant acinetobacter. J. Global Infect. Dis., 2: 291-304.
CrossRef  |  Direct Link  |  

Mardani, M., 2009. Worldwide attention to resistant bacteria. Arch. Clin. Infect. Dis., 4: 1-2.

Mardani, M., 2011. Pan-resistant Acinetobacter baumannii: Is there any available alternative therapy?. Arch. Clin. Infect. Dis., Vol. 6,

Mardani, M., 2014. Approaches to treat patients infected with multi-drug-resistant Acinetobacter baumannii. Arch. Clin. Infect. Dis., 8: 1-2.

Mohajeri, P., A. Farahani, M.M. Feizabadi, H. Ketabi, R. Abiri and F. Najafi, 2013. Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: A study in Western Iran. Iran. J. Microbiol., 5: 195-202.
Direct Link  |  

Mohseni, S., M. Aghayan, A. Ghorani-Azam, M. Behdani and A. Asoodeh, 2014. Evaluation of antibacterial properties of Barium Zirconate Titanate (BZT) nanoparticle. Braz. J. Microbiol., 45: 1393-1399.
CrossRef  |  Direct Link  |  

Moosavian, M., S. Shoja, R. Nashibi, N. Ebrahimi, M.A. Tabatabaiefar, S. Rostami and A. Peymani, 2014. Post neurosurgical meningitis due to colistin heteroresistant Acinetobacter baumannii. Jundishapur J. Microbiol., Vol. 7, No. 10.

Noori, N., J. Vandyosefi, F. Sabet, S. Ashrafi and K. Ghazvini, 2013. Frequency of IMP-1 and VIM Genes among Metallo-beta-Lactamase producing Acinetobacter spp. Isolated from health care associated infections in Northeast of Iran. J. Med. Bacteriol., 2: 11-16.
Direct Link  |  

Perez, F., A.M. Hujer, K.M. Hujer, B.K. Decker, P.N. Rather and R.A. Bonomo, 2007. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother., 51: 3471-3484.
CrossRef  |  PubMed  |  

Petersen, K., M.S. Riddle, J.R. Danko, D.L. Blazes, R. Hayden, S.A. Tasker and J.R. Dunne, 2007. Trauma-related infections in battlefield casualties from Iraq. Annl. Surg., 245: 803-811.
Direct Link  |  

Rashidian, S., N.H. Khayyat, M. Nakhaee, A. Sadeghian and K. Ghazvini, 2014. Trend of antibiotic resistance among Acinetobacter spp. Strains isolated from wound infections in Ghaem University Hospital in Northeast of Iran from 2005 to 2011. Razavi Int. J. Med., Vol. 2, No. 3.

Saed, S., M. Yazdanpanah, M. Lal-Dehghani, A. Khalighi, M. Honarmand, P. Afrough and K. Ghazvini, 2013. Emerging trend of acinetobacter nosocomial infection in Northeast of Iran. J. Med. Bacteriol., 2: 56-61.
Direct Link  |  

Safari, M., M. Saidijam, A. Bahador, R. Jafari and M.Y. Alikhani, 2013. High prevalence of multidrug resistance and Metallo-beta-Lactamase (MβL) producing Acinetobacter baumannii isolated from patients in ICU wards, Hamadan, Iran. J. Res. Health Sci., 13: 162-165.
PubMed  |  Direct Link  |  

Sepahi, S., A. Ghorani-Azam, S. Sepahi, A. Asoodeh and S. Rostami, 2014. In vitro study to evaluate antibacterial and non-haemolytic activities of four Iranian medicinal plants. West Indian Med. J., 63: 289-293.

Spellberg, B., M. Blaser, R.J. Guidos, H.W. Boucher and J.S. Bradley et al., 2011. Combating antimicrobial resistance: Policy recommendations to save lives. Clin. Infect. Dis., 52: S397-S428.

Zaniani, F.R., K. Ghazvini, A. Sadeghian, R. Reihani, M. Bagheri and M.D. Hosseini, 2010. Resistent acinetobacter wound infection in Orthopaedics. Iran. J. Orthopaedic Surg., 18: 40-43.
Direct Link  |  

Zolldann, D., H. Haefner, C. Poetter, S. Buzello, D. Sohr, R. Luetticken and S.W. Lemmen, 2003. Assessment of a selective surveillance method for detecting nosocomial infections in patients in the intensive care department. Am. J. Infect. Control, 31: 261-265.
Direct Link  |